. A micropenis has been defined as a penis < 7.5 cm in the erect length or < 4 cm in the flaccid state (Wessells, Lue, & McAninch, 1996) . This is based on 2.5 SD below the mean for age. Thus, in a series of 250 men who complained of a small penis, 98% had normal penile measurements, two (0.8%) patients had a buried penis and only two (0.8%) had a true micropenis (Ghanem et al., 2007) .
Some men with small penis anxiety may be diagnosed with Body Dysmorphic Disorder (BDD) (American Psychiatric Association, 2013) . Individuals with BDD are preoccupied with a perceived defect or flaw in their physical appearance that is not observable to others or appears only slight. To fulfil the diagnostic criteria for BDD, they should be preoccupied for at least an hour a day (Phillips, 1996) and must also experience clinically significant distress or impairment in social, occupational, or other important areas of functioning. Individuals with BDD are frequently preoccupied with several features of the face or body. Occasionally, in men, it is focussed on their genitals Veale et al., 2015) . It is important to identify BDD, as it may be associated with a high rate of psychiatric hospitalization, suicide ideation, and completed suicide (Phillips, Coles, et al., 2005) . It is often poorly identified because of shame and stigma, as patients do not often reveal their problem or they may present with symptoms of depression, social anxiety or obsessive-compulsive disorder when their main problem is BDD (Phillips, Nierenberg, Brendel, & Fava, 1996) . BDD can also be effectively treated with cognitive behavior therapy (CBT) (Veale, Anson, et al., 2014; Wilhelm et al., 2014) and SSRIs (Phillips, Albertini, & Rasmussen, 2002) . It is not known how many men with small penis anxiety also meet the criteria for BDD. A number of surgical studies have described men seeking phalloplasty as having penile dysmorphia but these were not reported as based on any structured diagnostic interview for BDD or a validated screening scale (Li et al., 2006; Perovic et al., 2006; Shamloul, 2005; Spyropoulos et al., 2005) . We use the term "penile dysmorphic disorder" (PDD) in this study as a problem description for men diagnosed with BDD, in whom the size or shape of the penis is their main, if not their exclusive, preoccupation causing significant distress and shame or handicap. A similar problem description exists with "muscle dysmorphia", a form of BDD in which patients (mainly men) are preoccupied with their muscles being too puny and are significantly distressed and handicapped (Pope, Gruber, Choi, Olivardia, & Phillips, 1997) . This is now coded in DSM 5 as a separate sub-type of BDD.
In clinical practice, sexual health physicians, urologists, counsellors, and psychotherapists may counsel men whose penis size is within the normal range, but who may be seeking a procedure to increase the length or girth of their penis.
Cosmetic phalloplasty is still regarded as experimental without any adequate outcome or evidence of safety (Ghanem, Glina, Assalian, & Buvat, 2013) . The diagnosis of BDD may be associated with poor outcome in most cosmetic procedures (Crerand, Menard, & Phillips, 2010; Phillips, Grant, Siniscalchi, & Albertini, 2001; Tignol, Biraben-Gotzamanis, Martin-Guehl, Grabot, & Aouizerate, 2007; Veale, De Haro, & Lambrou, 2003) . Therefore, a urologist who offers phalloplasty to men with PDD would be unwise but it might be used as an experimental intervention in men without BDD. There have also not been any trials of standard treatments (e.g., CBT, SSRIs) in men with PDD as clinically they may be more difficult to engage and treat compared to other appearance concerns with BDD in both sexes.
Most men with small penis anxiety are too ashamed to seek help and may instead seek solutions on the Internet. These include visiting sites that promote lotions, pills, exercises or penile extenders. There is one case series of a penile extender for men (Gontero et al., 2009 ) that used the Erectile Function subscale of the International Index of Erectile Function and a non-validated satisfaction questionnaire at posttreatment only. There are no case series or controlled trials of any psychological intervention for men with small penis anxiety, with or without PDD, other than an outcome of preventing surgery to increase size (Ghanem et al., 2007; Shamloul, 2005) .
One problem is that there are no adequate outcome measures for interventions. Using non-validated measures is problematic for several reasons: first, comparisons of findings between studies are difficult or impossible. Second, inadequate psychometric data make assessment of the effect size of any treatment difficult.
The aim of the current study was to develop (1) a screening questionnaire that was brief, free to download, and could identify men with PDD who may require specialist assessment, (2) a research tool that might predict either dissatisfaction with a surgical intervention or no change or deterioration in overall symptoms of BDD, and (3) a measure that is potentially sensitive to change after any intervention and can be used for future audits and controlled trials in the treatment of men with anxieties about the size of their penis.
METHOD Participants
Participants were categorized as (1) men with small penis anxiety with PDD, (2) men with small penis anxiety without PDD, and (3) a control group of men unconcerned with their penis size. All men were recruited from one of three sources:
(1) staff and students at King's College London (n = 38), (2) the Mind Search database of volunteers at the Institute of Psychiatry, Kings College London (n = 4), and (3) a link on the website for a popular television series "Embarrassing Bodies"
http://www.channel4embarrassingillnesses.com. It raises awareness of body image and illness concerns while allowing members of the public to understand their own embarrassing bodily concerns (n = 39). In total, 81 participants were included in the study. The demographic data are shown in Table 1 .
Measures
All participants completed the following questionnaires online.
Demographic Information
Information was obtained on age, marital status, ethnic origin, education, sexual orientation, and employment status.
Cosmetic Procedure Screening Scale for PDD (COPS-P)
This questionnaire was based on the original COPS for general appearance concerns and is a 9-item self-report scale (Veale et al., 2013) . This is validated as a screening questionnaire for identifying BDD. We modified the wording to focus on worries about the penis (see Table and Appendix 1 for final version). Participants respond on a Likert scale ranging from 0 ("Not at all") to 8 ("Extremely"). Questions 1 and 3 are reverse scored. A total score was calculated by summing all items. Higher scores reflect increased preoccupation and distress over the shape or size of the penis and therefore the likelihood of a diagnosis of BDD. (Veale, Eshkevari, et al., 2014) The BAPS is a 10-item self-report scale that measures beliefs about masculinity and shame about penis size. Two of the items measure internal selfevaluative beliefs, such as feeling abnormal (e.g., "I will never feel just right"). Three items describe a social cognitive component with predictions such as "Others will talk about my penis or laugh at it". There are four items on anticipated consequences of a small penis size, such as having to avoid situations where they may be naked (e.g., "I
Beliefs about Penis Size (BAPS)
will not be able to be naked in front of women"). Lastly, there are two items on extreme self-consciousness (e.g., "Others will be able to see the size or shape of my penis even when I have my trousers on"). The participant was asked to rate how strongly he agreed or disagreed with each statement, using a 5-point Likert scale from 0 ("Strongly disagree") to 4
("Strongly agree"). Total scores ranged from 0 to 40. A higher score therefore represents a greater level of insecurity and shame about penis size. Cronbach's alpha for the scale was .95, indicating strong internal reliability. (Zigmond & Snaith, 1983) The 14 items corresponding to the depression and anxiety subscales from the HADS were used to examine the severity of these symptoms. Each subscale was comprised of seven items and the possible range of scores was from 0 to 21 on each subscale. Higher scores represent increased severity of anxiety and depression.
Hospital Anxiety and Depression Scale (HADS)
Cronbach's alpha for the Anxiety subscale was .86 and Depression subscale was .83.
Social Phobia Inventory (SPIN) (Connor et al., 2000)
The SPIN is a 17-item self-report scale that measures the severity of performance and social anxiety. None of the items is specific to sexual situations. The participant rated each item on a 5-point Likert scale. The possible range of scores was from 0 (not at all) to 4 (extremely). Higher scores represent increased severity of social phobia and has a cut-off score of >19. Cronbach's alpha was .95. (Cash & Fleming, 2002; Hrabosky et al., 2009) The BIQLI is a 19-item self-report scale that measures the impact of body image concerns on a broad range of life domains (e.g., social functioning, sexuality, emotional well-being). Each item was rated by the participant on a 7-point Likert Scale, ranging from -3 (very negative effect) to + 3 (very positive effect). The BIQLI is scored as an average numeric score of the 19 items where a more negative score reflects a more negative body image. Cronbach's alpha was .97. (Rosen et al., 1997) The IIEF is a 15-item self-report scale that has five subscales: Erectile 
Body Image Quality of Life Inventory (BIQLI)

International Index of Erectile Function (IIEF)
Procedure
We sought in our email to recruit men to a study that was interested in their beliefs and fears about their penis size. They had to be aged 18 years or older and proficient in English in order to provide consent and complete the questionnaires online. All participants were interviewed by a trained research worker using the BDD Module in the Structured Clinical Interview for DSM-IV disorders (SCID) (First, Spitzer, Gibbon, & Williams, 1995) . This was to see whether or not their preoccupation with their penis size met criteria for a diagnosis of BDD. Criteria for meeting diagnosis according to the SCID are being preoccupied by the feature of concern for an hour or more per day, and if the preoccupation causes significant distress and impairment in social or occupational functioning. In addition, the symptoms must not be accounted for by another mental disorder. Those who met all of the criteria were classified in the PDD group. If they were anxious about penis size and did not have BDD, then they were categorized in the SPA group. Participants were measured (flaccid and erect, length and girth) by a urologist in a hospital outpatient clinic. On arrival, participants completed a consent form and were then given privacy in an air-conditioned consulting room at a constant temperature (21°C) at sea level.
Using a disposable tape measure, each participant had three parameters measured:
circumference (girth) of the penile mid shaft; length from suprapubic skin to distal glans (skin-to-tip); and pubis to distal glans (bone-to-tip). The three measurements were recorded in the stretched flaccid state, grasping the glans and exerting a stretching force until the participant felt mild discomfort to obtain maximum stretch.
After the flaccid measurements were taken, each participant was offered the chance to watch pornography on a provided laptop. Watching pornography was either accepted and chosen privately and anonymously or declined. At this point, the urologist left the room. Participants pressed a digital bell to alert the urologist when they were erect and ready to repeat the measurements. Three men were unable to achieve full erection and they received an intra-cavernous injection of 10 micrograms of Prostaglandin E1, administered by a urologist. The three measurements were then repeated in the fully erect state without stretching. Participants were given a £10
shopping voucher to thank them for participating in each part of the study.
Statistical Analysis
The three groups were initially compared on demographic variables. The groups were then compared on COPS-P item scores. As scores were significantly different to a normal distribution, Kruskal-Wallis and post-hoc Mann-Whitney-U tests were used to determine which items of the COPS-P were most sensitive at discriminating between the PDD group and those with small penis anxiety, without PDD. The most sensitive items were used to form the final questionnaire. Receiver
Operating Characteristics (ROC) analysis was used to assess sensitivity and specificity of the COPS-P in discriminating between the PDD and small penis anxiety group. To determine the optimal cut-off value of the COPS-P for the identification of men with PDD, kappa coefficients were computed for different cut-off scores. The internal consistency was evaluated using Cronbach's alpha. Spearman's rho correlation was used between the COPS-P and the HAD Depression, HAD Anxiety, BAPS, SPIN, BIQL, IIEF subscales, overall satisfaction score, and importance attached to penis size and actual penis size to test convergent validity. In order to test for group theoretical differences, COPS-P scores from the control group were compared to participants with PDD and participants with small penis anxiety. Where multiple comparisons were conducted, Bonferroni corrections were applied so all post-hoc effects are reported at a .0167 level of significance. To reduce missing data from partially completed questionnaires, the average score was computed for questionnaires where only one item was missing. This value was then entered for unanswered questions. Where more than one item was missing from a questionnaire, the average score was not computed and total scores were not included in the analyses
RESULTS
Demographics
Men with PDD were significantly older than the small penis anxiety and control group participants (Table 1) .
Item Response
Items that showed a significant difference between the groups and had an effect size (Cohen's d) of at least 1.25 were retained in the item discriminatory analysis. This effect size was considered very strong and we chose it, as we hoped to keep the scale to nine items, as this was the length of the original COPS (Veale et al., 2011) . Nine items met these criteria and were used to form the final questionnaire (see Table 2 ).
Two items that featured in the original COPS for general appearance concerns (Veale et al., 2011) did not meet criteria to be included in the COPS-P. These items were items (1) frequency of checking and (6) interference with relationships or dating.
These two items were, therefore, removed and were replaced by two items with higher effect size items (7) interference in sexual relationships and (11) interference in leisure activities.
ROC Analysis of the COPS-P
ROC analysis was conducted to explore cut-off scores, sensitivity, and specificity. Figure 1 represents the ROC curve for men with PDD compared to men with SPA. The area under the curve (AUC) was good (0.95, 95% CI = 0.90-1). To determine an optimal cut-off value, kappa coefficients were computed for each cut-off score. The highest kappa coefficient indicated the optimal sensitivity and specificity for cut-off values. As shown in Table 3 , a cut-off score of 40 yielded the highest kappa coefficient, sensitivity, and specificity (k = 0.82), based on the discrimination between those with PDD and those with small penis anxiety. On the basis of this cut-off score, 14 (78%) cases of PDD were correctly classified. Table 4 shows the sensitivity, specificity, and kappa coefficients, for a range of COPS-P cut-off scores designed to discriminate between men with and without PDD.
Reliability and Internal Consistency
Internal consistency for the 9-item COPS-P was calculated. Cronbach's alpha was .94 for all the participants, indicating good internal consistency. There were no items whose removal would improve the reliability of the measure.
Concurrent Validity
Concurrent validity was analyzed through Spearman's rho correlations with related measures. We examined the relationship between the COPS-P and the BAPS, HADS-Depression, HADS-Anxiety, SPIN, BIQL, and IIEF subscales (see Table 4 ). Validity: Group Differences Total 9-item COPS-P scores significantly differed between the three groups (see Table 5 ). COPS-P scores from the PDD group were significantly higher than those from the SPA group and the control group with large effect sizes. Additionally, COPS-P scores for those with SPA were significantly higher than control group scores.
DISCUSSION
This is the first study to develop a scale that was able to discriminate between those who had small penis anxiety with BDD and those who did not. We were able to demonstrate that the 9-item measure had good internal consistency with high internal reliability. The scale correlated significantly with the HADS-Depression, HADSAnxiety, Body Image Quality of Life, Social Phobia, and all but one of the IIEF scales.
Of note is that the weakest correlation of the COPS-P was with two IIEF subscales, "Orgasmic Function" and "Sexual Desire", which would not be expected to be affected by worries about penis size. The COPS-P was not correlated with girth or non-erect penis length (and only weakly with erect size). This is consistent with previous research in body image that has found that there is no relationship between objective unusualness of a body feature and psychological distress (Moss, 2005; Ong et al., 2007) .
The COPS-P is potentially part of an assessment of men presenting with small penis anxiety along with the Beliefs about Penis Size (Veale, Eshkevari, et al., 2014) .
Urologists and psychosexual counsellors can use such scales to help determine whether their patient may be best referred to a specialist psychiatric setting if they have possible BDD or can be treated by a sexual or health psychologist attached to the clinic. The COPS-P might be expected to correlate with the frequency of avoidance (e.g., of sexual situations or changing rooms); safety seeking behaviors (e.g., covering the genital area or use of objects to increase the bulk of the genital area) and cognitive processes (such as worry and self-focussed attention).
Limitations and Future Directions
The main limitation of this study was the use of a non-clinical convenience population. Therefore, bias in the results may occur with confounding variables linked to participants who are willing to partake in research in comparison to those with more extreme symptoms of small penis anxiety or PDD who would not be comfortable participating in the research. However, our participants in the PDD or SPA groups reported feeling too ashamed to seek help from normal routes of referral. In addition, it was initially necessary to recruit a large enough sample to investigate the psychometric properties of the scale. Furthermore, while the sample were a non-clinical population, they did have the opportunity to simultaneously take part in a randomized controlled trial investigating the efficacy of a treatment for small penis anxiety.
The self-report questionnaires being used to differentiate the control group may be limited by desirability bias and less reliable due to their inclusion of Likert scales, which can cause difficulty when operationalizing measures.
We did not expect our sample to be conducted in a relatively large proportion of homosexual men. It may be that homosexuality is a risk factor for concern with penis size because homosexual men might have more opportunity to compare their size to other men. Those who are homosexual may also be more likely to search the recruitment website or be willing to take part in related research. Existing qualitative research in men worried by penis size has suggested that homosexual men are subject to a number of stereotypes relating to penis size, such as a larger size is both more satisfying and portrays masculinity, which are thought to be influenced by Western culture (Drummond & Filiault, 2007) .
Additionally, while the relationship did not reach significance, frequencies did suggest that more men with PDD were married in comparison to men with SPA. This may be related to the older age of the PDD group. Further research would need to investigate whether this is a true difference. For example, the influence of a partner's opinion on genitalia or existing marital problems may have contributed to the development of BDD.
A further limitation was that no test retest reliability was conducted and so we are unable to conclude that the scale has external reliability. However, the original COPS for general appearance concerns (Veale et al., 2011) was tested for re-test reliability after 1 week and found that the measurement outcomes were consistent over time and strongly correlated (r = 0.87, p < .01). Future studies will be required to validate the scale in a clinical setting such as a urology or psychosexual clinic, and conduct test-retest reliability.
The scale has not yet been validated for sensitivity to change after any treatment. However, it was able to differentiate between those men who had PDD and those who did not. Future studies will need to validate the scale in men who are undergoing any intervention to determine whether it is effective in reducing symptoms of BDD. Lastly, it will important to determine the characteristics of men with PDD and small penis anxiety to understand the phenomenology and the risk factors in the development of the problem.
Conclusions
The current study was an initial validation on a brief self-report scale that can be used by clinicians and researchers to screen for BDD and potentially for audit and outcome research in all men worried abut their penis size. 6) How much do your concerns about the size or appearance of your penis currently interfere with your ability to work or study? (Please rate this even if you are not working or studying: we are interested in your ability to work or study). 
COPS-P for men
